After the transaction, Shaffer James P's stake was reported as 26,300 shares of Halozyme Therapeutics Inc stock.
As noted on November 14, 2012, Shaffer James P's purchase was done directly over 1 transaction on November 14, 2012. The share price for the transaction was $5.22 according to the regulatory filing detailing the trade.
If we look over the past 12 months, Shaffer James P has sold no shares of Halozyme Therapeutics Inc stock. Over the same time period, Shaffer James P has purchased 20,000 shares of Halozyme Therapeutics Inc, with a total cost of $104,400.
Let's take a quick, high-level look at insider trading at Halozyme Therapeutics Inc over the past 12 months. No shares of Halozyme Therapeutics Inc stock were sold by company insiders. Over the same time 12 month time period, 3,383,634 shares of Halozyme Therapeutics Inc, for a total value of $29,846,869 were purchased by company insiders.
To view the complete SEC Filing: Halozyme Therapeutics Inc Form 4 (Insider Trading) SEC Filing
